Log In
Print
BCIQ
Print
Print this Print this
 

apaziquone (EOquin) (formerly EO9, Neoquin)

  Manage Alerts
Collapse Summary General Information
Company Spectrum Pharmaceuticals Inc.
DescriptionAnalog of mitomycin C that is reduced by intracellular reductases into active DNA-damaging moieties
Molecular Target DNA
Mechanism of ActionBreaks/crosslinks DNA
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationBladder cancer
Indication DetailsTreat bladder cancer; Treat non-muscle invasive bladder cancer (NMIBC); Treat recurrent superficial bladder cancer (SBC); Treat superficial bladder cancer (SBC)
Regulatory Designation

U.S. - Special Protocol Assessment (Treat non-muscle invasive bladder cancer (NMIBC))

Partner

Handok Inc.; Nippon Kayaku Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today